Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

Also called NCT06264427

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06264427
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greenland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06264427. Allocation not applicable; no masking; primary purpose treatment. Start 2022-07-15 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
Condition
Diabetes Mellitus, Type 2
Condition
Obesity, Morbid
Condition
Obstructive Sleep Apnea
Condition
MODY
Condition
Diabetic Retinopathy
Condition
Diabetic Neuropathies
Intervention (Genetic)
Whole genome sequencing
Intervention (Diagnostic test)
VAGUS
Intervention (Diagnostic test)
NightOwl
Intervention (Device)
CPAP
Lead sponsor
Steno Diabetes Center Greenland (class: other)
Collaborator
Zealand University Hospital (class: other)
Collaborator
University of Copenhagen (class: other)

Record details

Record id
cardio:ct-nct06264427
Content hash
3a832ee829b064d7b1284291be8fc11828e029b71df8dd372cc6d2c697d0512e